ReShape Lifesciences Inc. (NASDAQ:RSLS – Get Free Report) saw a large increase in short interest in July. As of July 15th, there was short interest totalling 1,720,000 shares, an increase of 272.0% from the June 30th total of 462,400 shares. Approximately 6.6% of the shares of the stock are short sold. Based on an average daily volume of 6,270,000 shares, the short-interest ratio is presently 0.3 days.
Wall Street Analysts Forecast Growth
Separately, Maxim Group reissued a “hold” rating on shares of ReShape Lifesciences in a report on Wednesday, July 17th.
Read Our Latest Stock Analysis on RSLS
ReShape Lifesciences Stock Up 3.7 %
ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) last issued its quarterly earnings data on Wednesday, May 15th. The medical device company reported ($0.09) earnings per share (EPS) for the quarter. The firm had revenue of $1.94 million for the quarter. ReShape Lifesciences had a negative return on equity of 207.78% and a negative net margin of 130.99%.
About ReShape Lifesciences
ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.
Recommended Stories
- Five stocks we like better than ReShape Lifesciences
- What is the Shanghai Stock Exchange Composite Index?
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- Profitably Trade Stocks at 52-Week Highs
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- What is a Death Cross in Stocks?
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for ReShape Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReShape Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.